Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$14,752,990
+$2,118,110 QoQ
Shares Held
12,300
-10.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.39%
of 13F equity value
Holder Rank
#1,048
of 4,622 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ZEVIN ASSET MANAGEMENT LLC holds $59,856,217 across 9 Drug Manufacturers - General names. LLY ranks #2 (24.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
76,892 | $19,349,102 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
12,300 | $14,752,990 | |
| 3 | NVS |
Novartis AG
|
74,291 | $11,642,885 | |
| 4 | AZN |
Astrazeneca PLC
|
58,678 | $11,126,522 | |
| 5 | AMGN |
Amgen Inc
|
3,256 | $1,179,062 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,318 | $683,363 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,006 | $506,118 | |
| 8 | PFE |
Pfizer Inc
|
14,641 | $352,555 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,752,990 | 12,300 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $12,634,880 | 13,737 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $14,070,786 | 13,093 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,000,525 | 9,175 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $9,456,478 | 12,131 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $10,352,781 | 12,535 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||